Aside from DTA mutations, persons with CH also recurrently carried variants in other genes associated with myeloid neoplasms such as JAK2, SRSF2 and SF3B1 (Supplementary Fig. 2 and Supplementary Table 2). This evidence concerns the gene JAK2 and myeloid neoplasm.